We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFM
7376
Aberdeen Municipal Income Fund
MFM
$220M
$2K ﹤0.01%
300
MIRM icon
7377
Mirum Pharmaceuticals
MIRM
$6.94B
$2K ﹤0.01%
+119
New +$1.46K
MMLP icon
7378
CALL
Martin Midstream Partners
MMLP
$95.9M
$2K ﹤0.01%
400
-2,400
-86% -$12.4K
NWG icon
7379
PUT
NatWest
NWG
$71.9B
$2K ﹤0.01%
371
-743
-67% -$4.13K
IMDX
7380
Insight Molecular Diagnostics
IMDX
$153M
$2K ﹤0.01%
53
-266
-83% -$10.5K
PARAA
7381
DELISTED
Paramount Global Class A
PARAA
$2K ﹤0.01%
+54
New +$2.6K
PEZ icon
7382
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22M
$2K ﹤0.01%
30
PGZ
7383
Principal Real Estate Income Fund
PGZ
$68.7M
$2K ﹤0.01%
85
PHUN icon
7384
Phunware
PHUN
$42.9M
$2K ﹤0.01%
32
+8
+33% +$699
PRTH icon
7385
Priority Technology Holdings
PRTH
$532M
$2K ﹤0.01%
325
-1,511
-82% -$9.76K
PXH icon
7386
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.9B
$2K ﹤0.01%
103
SCOR icon
7387
Comscore
SCOR
$108M
$2K ﹤0.01%
61
-563
-90% -$32.5K
TMQ
7388
Trilogy Metals
TMQ
$529M
$2K ﹤0.01%
+1,000
New +$2.02K
TRMD icon
7389
TORM
TRMD
$3.04B
$2K ﹤0.01%
208
+1
+0.5% +$8
VEON icon
7390
CALL
VEON
VEON
$3.6B
$2K ﹤0.01%
+40
New +$2.74K
VRDN icon
7391
Viridian Therapeutics
VRDN
$2.19B
$2K ﹤0.01%
195
-331
-63% -$7.32K
WF icon
7392
Woori Financial
WF
$16.4B
$2K ﹤0.01%
76
-4,250
-98% -$135K
WRAP icon
7393
Wrap Technologies
WRAP
$100M
$2K ﹤0.01%
406
-1,725
-81% -$7.87K
CFB
7394
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$2K ﹤0.01%
+177
New +$2.55K
INSI
7395
DELISTED
Insight Select Income Fund
INSI
$2K ﹤0.01%
+120
New +$2.4K
AINC
7396
DELISTED
Ashford Inc.
AINC
$2K ﹤0.01%
75
-25
-25% -$686
VJET
7397
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$2K ﹤0.01%
160
ACER
7398
DELISTED
Acer Therapeutics Inc
ACER
$2K ﹤0.01%
890
-515
-37% -$1.51K
SURF
7399
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$2K ﹤0.01%
1,275
-428
-25% -$935
NMTR
7400
DELISTED
9 Meters Biopharma
NMTR
$2K ﹤0.01%
116
-39
-25% -$788

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.